Ganga Pharmaceuticals Ltd. is proposing an Initial Public Offering (IPO) on the BSE SME platform under the SME category.
Subscription opens 29 Jan 2016, closes 09 Feb 2016. Listing expected 17 Feb 2016. Apply via ASBA or UPI.
Ganga Pharmaceuticals Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 8,000 | ₹120,000 |
| Retail (Max) | 13 | 104,000 | ₹1,560,000 |
| sNII (Min) | 14 | 112,000 | ₹1,680,000 |
| bNII (Min) | 68 | 544,000 | ₹8,160,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |